Zydus Cadila arm gets USFDA nod for plaque psoriasis drug Apremilast ruchika25 Sep 2021 7:27 AM GMTAhmedabad: Drugmaker Zydus Cadila has recently announced that the company's U. S. subsidiary Zydus Pharmaceuticals Inc. has received final approval fro...
Conduct phase 3 trial of plaque psoriasis FDC drug on Indian patients: CDSCO panel tells Glenmark Medical Dialogues Team22 Aug 2021 6:00 AM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Organization (CDSCO) has recommended Glenmark Pharmaceuticals ...
Bimekizumab scores over adalimumab in achieving plaque psoriasis clearance: NEJM Medha28 April 2021 5:20 AM GMTUK: Bimekizumab was shown to be noninferior and superior to adalimumab in reducing signs and symptoms of plaque psoriasis in a 56-week trial. However, ...
Unichem Labs plaque psoriasis drug Apremilast gets USFDA nod ruchika19 Feb 2021 8:30 AM GMTMumbai: Unichem Laboratories Limited, today announced that the company has received abbreviated new drug application (ANDA) approval for its Apre...
Benvitimod cream: a new topical treatment for plaque psoriasis Hina Zahid20 Jan 2021 12:45 PM GMTPsoriasis is a chronic inflammatory skin disease characterized by erythematous (red) patches and plaques. In some patients, psoriasis may be...
Sun Pharma begins Phase 2 Trial of SCD-044 for Plaque Psoriasis ruchika5 Jan 2021 7:11 AM GMTMumbai: Sun Pharmaceutical Industries Limited today announced that the company has initiated Phase 2 clinical trial for SCD-044 (a novel, orally bioav...
Sun Pharma reports five-year positive results for ILUMYA in Plaque Psoriasis patients ruchika2 Nov 2020 8:04 AM GMTILUMYA is approved for adults with moderate-to-severe plaque psoriasis and is being evaluated for other possible uses.
Risankizumab superior to ustekinumab for treating plaque psoriasis: JAMA Medha16 Oct 2020 1:08 PM GMTUSA: Treatment of plaque psoriasis patients with risankizumab improved symptoms, health-related quality of life, and reduced psychological distress,...
Sun Pharma Japanese arm unveils Ilumya to treat plaque psoriasis ruchika24 Sep 2020 11:15 AM GMTPsoriasis is a chronic immune disease that appears on the skin.
Topical roflumilast improves chronic plaque psoriasis, finds new research Dr. Kamal Kant Kohli18 July 2020 1:30 AM GMTResearchers at the Icahn School of Medicine report that roflumilast cream (ARQ-151), which contains a highly potent, selective phosphodiesterase-4...
Sun Pharma gets Japanese nod to Plaque Psoriasis drug ILUMYA ruchika30 Jun 2020 6:00 AM GMTThe drug offers a new treatment option with only one injection every 12 weeks for Japanese patients who struggle every day with the chronic nature of...
Sun Pharma inks exclusive pact with Hikma to distribute ILUMYA in Middle East, North Africa ruchika16 Jun 2020 6:11 AM GMTILUMYAâ„¢ (tildrakizumab) is a USFDA approved innovative IL-23p19 monoclonal antibody used for the treatment of adults with moderate-to-severe plaque...
